Market Structure/Political trading
Which Small Caps Does Congress Trade, and What Did They File Next?
Congressional trades in companies under $2 billion and $300 million since 2025, and the SEC filings those companies made in the 90 days after each trade.
Look up any company's filings, insider trades and dilution on Signal8.
Key takeaways
- Of 12,520 congressional common-stock trades made from January 2025 and disclosed by November 16, 2026, 318 (2.5%) were in companies valued under $2 billion on the trade date.
- Only 82 were in companies valued under $300 million, and 78 of those were sales.
- In the 90 days after a member first traded a company under $2 billion, 87 of 94 companies filed a quarterly or annual report and 13 filed an offering document.
- Most of what these companies filed next was routine. A filing that follows a trade is a date on a calendar, not evidence of why anyone traded.
The short version
Members of Congress rarely trade small companies. Signal8's count: of 12,520 common-stock trades made from January 1, 2025 and disclosed by November 16, 2026, 318 (2.5%) were in companies with a market value under $2 billion on the trade date, spread across 99 companies and 29 members. Only 82 trades were in companies under $300 million, and 78 of those 82 were sales.
In the 90 days after a member's first trade in one of those small companies, the companies mostly filed what every listed company files: quarterly results and 8-Ks. Everything here is a fact of record from two public sources, the members' Periodic Transaction Reports and the companies' SEC filings. Nothing in it suggests that any trade was based on non-public information, and a filing that came after a trade is not evidence of why anyone traded.
How small the small-cap trades are
Trades in common stock, by the company's market value on the trade date (last close times the shares outstanding stated on its latest SEC filing):
| Market value on the trade date | Trades | Companies | Members | Purchases | Sales |
|---|---|---|---|---|---|
| Under $300 million | 82 | 13 | 11 | 4 | 78 |
| $300 million to $2 billion | 236 | 88 | 26 | 116 | 119 |
| $2 billion to $5 billion | 387 | 131 | 29 | 216 | 168 |
The other trades were in companies valued above $5 billion, or could not be measured (see the method notes). The under-$300 million group is concentrated: as recorded in our data, two Senate reports account for 56 of its 82 trades, all sales of one company's stock by one senator's spouse.
What the companies filed in the next 90 days
For each of the small companies, the window starts the day after the first trade by a member and runs 90 days. 94 companies had a complete window by November 16, 2026:
| Filed within 90 days after the trade | Companies | Share |
|---|---|---|
| Quarterly or annual report (10-Q, 10-K, 20-F) | 87 | 92.6% |
| 8-K with results (Item 2.02) | 83 | 88.3% |
| 8-K on an officer or director change (Item 5.02) | 48 | 51.1% |
| 8-K on a material agreement (Item 1.01) | 22 | 23.4% |
| S-8 (employee stock plan registration) | 14 | 14.9% |
| Offering document (S-1, S-3, F-1, F-3 or 424B prospectus) | 13 | 13.8% |
| 8-K on an acquisition or disposition (Item 2.01) | 9 | 9.6% |
| 8-K on a listing deficiency (Item 3.01) | 4 | 4.3% |
| Form 25 or Form 15 (delisting or deregistration) | 3 | 3.2% |
These shares are not compared with companies Congress did not trade, so they show what was filed, not whether it was unusual. A 90-day window almost always contains a quarterly report and its results release. What each 8-K item means is in the 8-K item codes guide.
The companies under $300 million, House trades
House reports are public PDFs, and every row below was checked against the member's report and the company's EDGAR filing list on November 17, 2026. Amounts are the disclosed ranges.
| Company | Member | Trades disclosed | Market value at the trade | Filed in the 90 days after the first trade |
|---|---|---|---|---|
| Century Casinos | Susie Lee | Sale, Mar 14, 2025, $1,001 to $15,000 | about $58 million | Proxy statement Apr 29; 10-Q and results 8-K May 12; 8-K (other events) May 14 |
| Full House Resorts | Susie Lee | 12 sales, Feb 13, 2025 to Jul 1, 2026, from $1,001 to $15,000 up to $500,001 to $1,000,000 | about $89 to $193 million | Results 8-K Mar 6; 10-K Mar 11; 8-K Item 4.01 (auditor change) Mar 19; 8-K Item 5.02 Apr 4; proxy Apr 7; results 8-K May 8; 10-Q May 9 |
| Genprex | Tim Moore | Purchases, Dec 18, 2025 and Feb 5, 2026, each $1,001 to $15,000 | about $5 million | Seven 8-Ks under Item 8.01 (other events), Dec 23 to Mar 18; S-8 Jan 9. Later, outside the window: a 1-for-22 reverse split effective Jul 16, 2026 (8-K, Jul 14) |
| TuHURA Biosciences | Laurel Lee (spouse) | Purchase, Jul 13, 2025, $50,001 to $100,000 | about $100 million | S-1 Aug 12 registering the resale of up to 9.5 million shares by selling stockholders; 10-Q and results 8-K Aug 14; 8-K Item 1.01 Sep 11; resale prospectus Sep 26 |
| Hurco Companies | Debbie Wasserman Schultz (dependent child) | Sale, Feb 6, 2025, $1,001 to $15,000 | about $144 million | 10-Q and results 8-K Mar 7; S-8 Mar 13; 8-K Items 5.02 and 5.07 Mar 17 |
| Mesabi Trust | Gilbert Ray Cisneros | Purchase, Jul 31, 2026, $15,001 to $50,000 | about $288 million | 10-Q Sep 11; results 8-K Oct 15 |
| Oramed Pharmaceuticals | Brad Knott | Sale, Jan 10, 2025, $15,001 to $50,000 | about $96 million | Four 8-Ks under Item 1.01, Jan 22 to Mar 3; 10-K Mar 27 |
| Virgin Galactic | George Whitesides | Sale, Mar 24, 2025, $1,001 to $15,000 | about $144 million | Proxy Apr 15; 10-Q, results 8-K and an at-the-market prospectus supplement (424B5, up to $300 million) May 15; S-8 Jun 5; 8-K Items 5.02 and 5.07 Jun 10 |
Kevin Hern's report of two sales of Vuzix stock by a dependent child on September 3, 2026 (each $1,001 to $15,000, about $206 million market value) is in the under-$300 million group, but its 90-day window ends December 2, 2026. Senate trades are counted in every table above but not named row by row: the Senate's disclosure site could not be opened from our checker on November 17, 2026, so those rows were not checked against the original reports.
Method and exclusions
- Trades: House and Senate Periodic Transaction Reports with a transaction date from January 1, 2025, disclosed by November 16, 2026, in securities classed as common stock (ETFs, funds, preferred shares, ADRs, bonds and options excluded). A line with a transaction date flagged as a probable typing error is excluded.
- Market value: the last close on or before the trade date, times the shares outstanding on the cover of the company's latest 10-Q or 10-K filed before the trade (SEC XBRL data). Companies valued above $5 billion on November 2026 data were not measured and are treated as not small. Not measured, and excluded rather than guessed (171 trades): no price on the trade date (61), no SEC share count (90), a share count more than 400 days old (15), a stock split between the share count and the trade (3), and one company whose stated share count covered only one class (2).
- Filings: each company's SEC EDGAR filing list. Filings on the trade date itself are excluded, because the reports do not give a time of day for the trade. Forms 3, 4, 5, Schedules 13D and 13G, and SEC correspondence are left out of the named table.
- No downloadable dataset. Under 5 U.S.C. 13107(c) the reports may not be used for most commercial purposes; this page publishes analysis and statistics only. The reports themselves are public on the House Clerk and Senate websites.
FAQ
Do members of Congress trade penny stocks?
Rarely. 82 of 12,520 congressional common-stock trades from January 2025 to November 2026 were in companies valued under $300 million, and 78 of those were sales.
Does a filing after a congressional trade mean the trade was informed?
No. Listed companies file 10-Qs, results releases and 8-Ks on a routine schedule, so almost any 90-day window contains several filings. The dates are facts of record; they do not show why anyone traded. Congressional trading data covers what the reports can and cannot tell you.
Where can I see every congressional trade in a stock?
Each company page on Signal8 lists the congressional trades disclosed in its stock, and the politicians page lists members and their reports. Late disclosures are counted in the STOCK Act report for 2026.
Terms in this guide
- Form 8-K
- A Form 8-K is the SEC current report a public company files, generally within four business days, to disclose material events such as agreements, offerings, executive changes and listing notices.
- Form S-3
- Form S-3 is the short-form SEC registration statement eligible reporting companies use for shelf offerings, letting them incorporate existing filings by reference and sell securities quickly.
Try it on Signal8
See this in live data with Congressional trades.
Compare tools
All comparisonsRelated guides
All Market Structure guidesMarket Structure
Congressional Stock Trading Data: What It Shows
Limits of congressional stock trading data: amount brackets, reporting lag, spouse and managed accounts, and why a disclosed trade says nothing about intent.
6 min read
Market Structure
STOCK Act Explained: Periodic Transaction Reports
The STOCK Act explained: how members of Congress disclose stock trades in Periodic Transaction Reports, the 30 and 45 day deadlines, ranges and late filings.
6 min read
Market Structure
STOCK Act Report 2026: Late Congressional Trade Disclosures So Far
How many STOCK Act trade reports members of Congress filed after the 45-day deadline in 2026 to date, by chamber and month, against 2022 to 2025.
5 min read
Market Structure
How to Find Small-Cap Catalysts Before They Run
How to find small-cap catalysts early: read 8-K items, press releases, FDA dates and trading halts as they are filed, with live counts from November 2026.
6 min read
Educational content only. Signal8 is not a broker-dealer or investment adviser, and nothing here is a recommendation to buy or sell any security.